ArticlePoultry science2026
Gentiana scabra mitigates Eimeria tenella-induced Coccidiosis by regulating the gut microbiota-metabolome and strengthening the intestinal barrier.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coccidiosis is a major parasitic threat to global poultry production. Chemical anticoccidial overuse raises residue and food safety concerns, spurring interest in safe, residue-free alternatives like Chinese herbal medicines. Gentiana scabra extract (GSE) shows broad bioactivity, but its anticoccidial efficacy against Eimeria tenella and gut microecological effects remain unclear. We evaluated three GSE doses (1, 2, 4 g/kg feed) in a controlled floor-pen experiment using broilers infected with E. tenella. Anticoccidial activity was assessed via McMaster oocyst counting and clinical indices: oocysts per gram (OPG), relative body weight gain (RBWG), survival rate (SR), and anticoccidial index (ACI). GSE alleviated intestinal lesions, improved SR and RBWG, Nand reduced OPG in a nonlinear, dose-dependent manner. The 2 g/kg dose achieved optimal efficacy (ACI = 163.5; moderate activity); lower (1 g/kg, ACI = 149.5) and higher (4 g/kg, ACI = 146.1) doses were less effective. GSE enhanced gut microbial α-diversity and richness, increased beneficial taxa (e.g., Butyricicoccus, Lachnospiraceae) and metabolites, and suppressed pathogens (Clostridium perfringens, Tyzzerella)-most robustly at 2 g/kg. Differential metabolites mapped predominantly to energy metabolism (pyruvate, TCA cycle) and host signaling (PI3K-AKT, mTOR, AMPK). This is the first study to demonstrate GSE's anticoccidial potential and link it mechanistically to gut microbiota-metabolome modulation-supporting its development as a multi-target, natural anticoccidial alternative.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.